Nina Capital

Nina Capital does not conduct clinical trials or have clinical results. It invests in early-stage healthtech startups that are transforming healthcare through information technology and digital innovation. Its portfolio includes over 50 companies across diagnostics, medical devices, clinician training tools, healthcare infrastructure optimization platforms, and operational efficiency solutions for hospitals[2][4][6]. Portfolio highlights include high graduation rates from seed to next funding stages (>80% for Fund I) and significant revenue growth among portfolio companies (~5x for Fund II within two years of initial investment)[8][10]. Example recent investment from Fund III includes Sonar Mental Health—a US-based mental health platform using AI and human-led support for students[7][8].